563 related articles for article (PubMed ID: 25682993)
1. Tacrolimus for remission induction in ulcerative colitis: Mayo endoscopic subscore 0 and 1 predict long-term prognosis.
Ikeya K; Sugimoto K; Kawasaki S; Iida T; Maruyama Y; Watanabe F; Hanai H
Dig Liver Dis; 2015 May; 47(5):365-71. PubMed ID: 25682993
[TBL] [Abstract][Full Text] [Related]
2. Mucosal healing with oral tacrolimus is associated with favorable medium- and long-term prognosis in steroid-refractory/dependent ulcerative colitis patients.
Miyoshi J; Matsuoka K; Inoue N; Hisamatsu T; Ichikawa R; Yajima T; Okamoto S; Naganuma M; Sato T; Kanai T; Ogata H; Iwao Y; Hibi T
J Crohns Colitis; 2013 Dec; 7(12):e609-14. PubMed ID: 23680174
[TBL] [Abstract][Full Text] [Related]
3. The Ulcerative Colitis Endoscopic Index of Severity More Accurately Reflects Clinical Outcomes and Long-term Prognosis than the Mayo Endoscopic Score.
Ikeya K; Hanai H; Sugimoto K; Osawa S; Kawasaki S; Iida T; Maruyama Y; Watanabe F
J Crohns Colitis; 2016 Mar; 10(3):286-95. PubMed ID: 26581895
[TBL] [Abstract][Full Text] [Related]
4. Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis.
Colombel JF; Rutgeerts P; Reinisch W; Esser D; Wang Y; Lang Y; Marano CW; Strauss R; Oddens BJ; Feagan BG; Hanauer SB; Lichtenstein GR; Present D; Sands BE; Sandborn WJ
Gastroenterology; 2011 Oct; 141(4):1194-201. PubMed ID: 21723220
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the Risk of Relapse in Ulcerative Colitis According to the Degree of Mucosal Healing (Mayo 0 vs 1): A Longitudinal Cohort Study.
Barreiro-de Acosta M; Vallejo N; de la Iglesia D; Uribarri L; Bastón I; Ferreiro-Iglesias R; Lorenzo A; Domínguez-Muñoz JE
J Crohns Colitis; 2016 Jan; 10(1):13-9. PubMed ID: 26351390
[TBL] [Abstract][Full Text] [Related]
6. Effect of mucosal healing (Mayo 0) on clinical relapse in patients with ulcerative colitis in clinical remission.
Kim JH; Cheon JH; Park Y; Lee HJ; Park SJ; Kim TI; Kim WH
Scand J Gastroenterol; 2016 Sep; 51(9):1069-74. PubMed ID: 26895215
[TBL] [Abstract][Full Text] [Related]
7. Long-term Outcomes in Steroid-refractory Ulcerative Colitis Treated with Tacrolimus Alone or in Combination with Purine Analogues.
Schmidt KJ; Müller N; Dignass A; Baumgart DC; Lehnert H; Stange EF; Herrlinger KR; Fellermann K; Büning J
J Crohns Colitis; 2016 Jan; 10(1):31-7. PubMed ID: 26419459
[TBL] [Abstract][Full Text] [Related]
8. Ulcerative colitis patients in clinical remission demonstrate correlations between fecal immunochemical test results, mucosal healing, and risk of relapse.
Nakarai A; Kato J; Hiraoka S; Takashima S; Takei D; Inokuchi T; Sugihara Y; Takahara M; Harada K; Okada H
World J Gastroenterol; 2016 Jun; 22(21):5079-87. PubMed ID: 27275100
[TBL] [Abstract][Full Text] [Related]
9. Is mucosal healing more common than clinical remission in ulcerative colitis? - Is it the truth or only a myth coming from the studies?
Rutka M; Milassin Á; Szepes Z; SzŰcs M; Nyári T; Bálint A; Bor R; Molnár T; Farkas K
Scand J Gastroenterol; 2015 Aug; 50(8):985-90. PubMed ID: 25733077
[TBL] [Abstract][Full Text] [Related]
10. Oral tacrolimus as maintenance therapy for refractory ulcerative colitis--an analysis of outcomes in two London tertiary centres.
Landy J; Wahed M; Peake ST; Hussein M; Ng SC; Lindsay JO; Hart AL
J Crohns Colitis; 2013 Dec; 7(11):e516-21. PubMed ID: 23623737
[TBL] [Abstract][Full Text] [Related]
11. Complete mucosal healing defined by endoscopic Mayo subscore still demonstrates abnormalities by novel high definition colonoscopy and refined histological gradings.
Iacucci M; Fort Gasia M; Hassan C; Panaccione R; Kaplan GG; Ghosh S; Gui X
Endoscopy; 2015 Aug; 47(8):726-34. PubMed ID: 25826276
[TBL] [Abstract][Full Text] [Related]
12. Mucosal Healing in Ulcerative Colitis--When Zero is Better.
Boal Carvalho P; Dias de Castro F; Rosa B; Moreira MJ; Cotter J
J Crohns Colitis; 2016 Jan; 10(1):20-5. PubMed ID: 26438714
[TBL] [Abstract][Full Text] [Related]
13. Endoscopic and histologic response to cyclosporine in ulcerative colitis and their impact on disease outcome: A cohort study.
Fron C; Pierry C; Poullenot F; Chabrun E; Subtil C; Capdepont M; Zerbib F; Belleannée G; Laharie D
Dig Liver Dis; 2016 Jul; 48(7):734-9. PubMed ID: 27052254
[TBL] [Abstract][Full Text] [Related]
14. Rate and Predictors of Mucosal Healing in Ulcerative Colitis Treated with Thiopurines: Results of a Multicentric Cohort Study.
Prieux-Klotz C; Nahon S; Amiot A; Sinayoko L; Galéano-Cassaz C; Chaussade S; Coriat R; Lahmek P; Abitbol V
Dig Dis Sci; 2017 Feb; 62(2):473-480. PubMed ID: 27853898
[TBL] [Abstract][Full Text] [Related]
15. The Ulcerative Colitis Endoscopic Index of Severity is Useful to Predict Medium- to Long-Term Prognosis in Ulcerative Colitis Patients with Clinical Remission.
Arai M; Naganuma M; Sugimoto S; Kiyohara H; Ono K; Mori K; Saigusa K; Nanki K; Mutaguchi M; Mizuno S; Bessho R; Nakazato Y; Hosoe N; Matsuoka K; Inoue N; Ogata H; Iwao Y; Kanai T
J Crohns Colitis; 2016 Nov; 10(11):1303-1309. PubMed ID: 27194529
[TBL] [Abstract][Full Text] [Related]
16. Relationship Between Combined Histologic and Endoscopic Endpoints and Efficacy of Ustekinumab Treatment in Patients With Ulcerative Colitis.
Li K; Marano C; Zhang H; Yang F; Sandborn WJ; Sands BE; Feagan BG; Rubin DT; Peyrin-Biroulet L; Friedman JR; De Hertogh G
Gastroenterology; 2020 Dec; 159(6):2052-2064. PubMed ID: 32853634
[TBL] [Abstract][Full Text] [Related]
17. Prognosis of ulcerative colitis differs between patients with complete and partial mucosal healing, which can be predicted from the platelet count.
Nakarai A; Kato J; Hiraoka S; Inokuchi T; Takei D; Moritou Y; Akita M; Takahashi S; Hori K; Harada K; Okada H; Yamamoto K
World J Gastroenterol; 2014 Dec; 20(48):18367-74. PubMed ID: 25561804
[TBL] [Abstract][Full Text] [Related]
18. Adalimumab for Induction of Histological Remission in Moderately to Severely Active Ulcerative Colitis.
Fernández-Blanco JI; Fernández-Díaz G; Cara C; Vera MI; Olivares D; Taxonera C
Dig Dis Sci; 2018 Mar; 63(3):731-737. PubMed ID: 29372480
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of infliximab as rescue therapy for ulcerative colitis refractory to tacrolimus.
Yamamoto S; Nakase H; Matsuura M; Honzawa Y; Masuda S; Inui K; Chiba T
J Gastroenterol Hepatol; 2010 May; 25(5):886-91. PubMed ID: 20546441
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with mucosal healing in patients with ulcerative colitis in clinical remission.
Shi HY; Chan FK; Tsang SW; Hui YT; Sze SF; Ching JY; Chung T; Iu CY; Lo FH; Shan EH; Li MK; Wu JC; Sung JJ; Ng SC
Inflamm Bowel Dis; 2015 Apr; 21(4):840-6. PubMed ID: 25738375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
